GSA CAPITAL PARTNERS LLP - AC IMMUNE SA ownership

AC IMMUNE SA's ticker is ACIU and the CUSIP is H00263105. A total of 37 filers reported holding AC IMMUNE SA in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of AC IMMUNE SA
ValueSharesWeighting
Q4 2021$362,000
+212.1%
73,046
+334.8%
0.04%
+55.2%
Q1 2020$116,000
-57.5%
16,800
-47.7%
0.03%
-9.4%
Q4 2019$273,000
+92.3%
32,100
+12.2%
0.03%
+68.4%
Q3 2019$142,000
+29.1%
28,600
+107.2%
0.02%
+216.7%
Q3 2018$110,000
-79.0%
13,801
-72.8%
0.01%
-78.6%
Q1 2017$525,000
+14.9%
50,697
+43.9%
0.03%
+3.7%
Q4 2016$457,00035,2330.03%
Other shareholders
AC IMMUNE SA shareholders Q3 2019
NameSharesValueWeighting ↓
BVF INC/IL 11,297,911$55,925,0005.88%
Prosight Management, LP 1,248,453$6,180,0003.43%
PA Capital LLC 76,257$377,0000.37%
Artal Group S.A. 1,000,000$4,950,0000.20%
Temasek Holdings (Private) Ltd 2,614,095$12,940,0000.10%
COHEN LAWRENCE B 13,350$66,0000.04%
Tekla Capital Management LLC 171,813$850,0000.04%
Athanor Capital, LP 108,540$537,0000.04%
GSA CAPITAL PARTNERS LLP 28,600$142,0000.02%
APPLETON PARTNERS INC/MA 11,525$57,0000.01%
View complete list of AC IMMUNE SA shareholders